These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 29416701)

  • 21. Chromosomes and expression in human testicular germ-cell tumors: insight into their cell of origin and pathogenesis.
    Looijenga LH; Gillis AJ; Stoop HJ; Hersmus R; Oosterhuis JW
    Ann N Y Acad Sci; 2007 Dec; 1120():187-214. PubMed ID: 17911410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Testicular germ cell tumours: the paradigm of chemo-sensitive solid tumours.
    di Pietro A; Vries EG; Gietema JA; Spierings DC; de Jong S
    Int J Biochem Cell Biol; 2005 Dec; 37(12):2437-56. PubMed ID: 16099193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Role of DNA/Histone Modifying Enzymes and Chromatin Remodeling Complexes in Testicular Germ Cell Tumors.
    Lobo J; Henrique R; Jerónimo C
    Cancers (Basel); 2018 Dec; 11(1):. PubMed ID: 30577487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular biomarkers as potential targets for therapeutic strategies in human testicular germ cell tumors: an overview.
    Chieffi P; Chieffi S
    J Cell Physiol; 2013 Aug; 228(8):1641-6. PubMed ID: 23359388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetics and Testicular Cancer: Bridging the Gap Between Fundamental Biology and Patient Care.
    Nicu AT; Medar C; Chifiriuc MC; Gradisteanu Pircalabioru G; Burlibasa L
    Front Cell Dev Biol; 2022; 10():861995. PubMed ID: 35465311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vasculogenesis and angiogenesis in nonseminomatous testicular germ cell tumors.
    Silván U; Díez-Torre A; Bonilla Z; Moreno P; Díaz-Núñez M; Aréchaga J
    Urol Oncol; 2015 Jun; 33(6):268.e17-28. PubMed ID: 25772688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent Advancements in Research on DNA Methylation and Testicular Germ Cell Tumors: Unveiling the Intricate Relationship.
    Nicu AT; Ionel IP; Stoica I; Burlibasa L; Jinga V
    Biomedicines; 2024 May; 12(5):. PubMed ID: 38791003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent advances in molecular and cell biology of testicular germ-cell tumors.
    Chieffi P
    Int Rev Cell Mol Biol; 2014; 312():79-100. PubMed ID: 25262239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An Overview on Predictive Biomarkers of Testicular Germ Cell Tumors.
    Chieffi P
    J Cell Physiol; 2017 Feb; 232(2):276-280. PubMed ID: 27405110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase II study of everolimus in refractory testicular germ cell tumors.
    Mego M; Svetlovska D; Miskovska V; Obertova J; Palacka P; Rajec J; Sycova-Mila Z; Chovanec M; Rejlekova K; Zuzák P; Ondrus D; Spanik S; Reckova M; Mardiak J
    Urol Oncol; 2016 Mar; 34(3):122.e17-22. PubMed ID: 26612480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of P53 and MDM2 in treatment response of human germ cell tumors.
    Kersemaekers AM; Mayer F; Molier M; van Weeren PC; Oosterhuis JW; Bokemeyer C; Looijenga LH
    J Clin Oncol; 2002 Mar; 20(6):1551-61. PubMed ID: 11896104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic role of programmed-death ligand 1 (PD-L1) expressing tumor infiltrating lymphocytes in testicular germ cell tumors.
    Chovanec M; Cierna Z; Miskovska V; Machalekova K; Svetlovska D; Kalavska K; Rejlekova K; Spanik S; Kajo K; Babal P; Mardiak J; Mego M
    Oncotarget; 2017 Mar; 8(13):21794-21805. PubMed ID: 28423520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imprints and DPPA3 are bypassed during pluripotency- and differentiation-coupled methylation reprogramming in testicular germ cell tumors.
    Killian JK; Dorssers LC; Trabert B; Gillis AJ; Cook MB; Wang Y; Waterfall JJ; Stevenson H; Smith WI; Noyes N; Retnakumar P; Stoop JH; Oosterhuis JW; Meltzer PS; McGlynn KA; Looijenga LH
    Genome Res; 2016 Nov; 26(11):1490-1504. PubMed ID: 27803193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An up-date on newly discovered immunohistochemical biomarkers for the diagnosis of human testicular germ cell tumors.
    Chieffi P; Chieffi S
    Histol Histopathol; 2014 Aug; 29(8):999-1006. PubMed ID: 24627150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biology of testicular germ cell tumors.
    Hussain SA; Ma YT; Palmer DH; Hutton P; Cullen MH
    Expert Rev Anticancer Ther; 2008 Oct; 8(10):1659-73. PubMed ID: 18925857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of human endogenous retrovirus type K-specific transcripts in testicular parenchyma and testicular germ cell tumors of adolescents and adults: clinical and biological implications.
    Roelofs H; van Gurp RJ; Oosterhuis JW; Looijenga LH
    Am J Pathol; 1998 Oct; 153(4):1277-82. PubMed ID: 9777959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The attractive Achilles heel of germ cell tumours: an inherent sensitivity to apoptosis-inducing stimuli.
    Spierings DC; de Vries EG; Vellenga E; de Jong S
    J Pathol; 2003 Jun; 200(2):137-48. PubMed ID: 12754734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent developments in testicular germ cell tumor research.
    van de Geijn GJ; Hersmus R; Looijenga LH
    Birth Defects Res C Embryo Today; 2009 Mar; 87(1):96-113. PubMed ID: 19306344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nodal/Cripto signaling in fetal male germ cell development: implications for testicular germ cell tumors.
    Spiller CM; Bowles J; Koopman P
    Int J Dev Biol; 2013; 57(2-4):211-9. PubMed ID: 23784832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parent-of-origin effects of A1CF and AGO2 on testicular germ-cell tumors, testicular abnormalities, and fertilization bias.
    Carouge D; Blanc V; Knoblaugh SE; Hunter RJ; Davidson NO; Nadeau JH
    Proc Natl Acad Sci U S A; 2016 Sep; 113(37):E5425-33. PubMed ID: 27582469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.